The student news site of The Harker School.

Harker Aquila

The student news site of The Harker School.

Harker Aquila

The student news site of The Harker School.

Harker Aquila

STEM Scene showcases briefs to update our community on the STEM world.

STEM Scene: Dec. 1

by Sriya Batchu and Julie Shi December 1, 2021

Space X launches Crew-3 flight SpaceX’s manufactured spacecraft Crew Dragon successfully launched flight SpaceX Crew-3 from the National Aeronautics and Space Administration (NASA) Kennedy Space...

A nurse prepares a Pfizer booster shot at the San Jose Valley Medical Center on October 18. After preparation, the booster can then be administered to elderly and immunocompromised citizens.

FDA approves Pfizer, Moderna and Johnson & Johnson booster shots, administration currently underway

by Edward Huang, Reporter October 26, 2021

The Food and Drug Administration (FDA) declared COVID-19 booster shots from Pfizer to be safe for individuals over the age of 65, people with compromised immune systems and essential workers on Sept. 22...

An illustration of the COVID-19 virus.
This article addresses common myths surrounding COVID-19, the delta variant and vaccines and provides accurate answers from the CDC and The New England Journal of Medicine.

Myth-busting COVID-19 and the vaccines

by Arjun Barrett and Nicole Tian August 28, 2021

Do I still need to wear a mask if I’m vaccinated? Yes. Though the CDC only requires unvaccinated individuals to wear a mask, all vaccinated individuals are encouraged to continue wearing masks. Unvaccinated...

The US Food and Drug Association gave full approval to the Pfizer-BioNTech COVID-19 vaccine on Monday for individuals older than sixteen years. Previously, the treatment was only administered under an emergency use authorization (EUA), which was granted in December 2020.

FDA approves Pfizer’s COVID-19 vaccine

by Sabrina Zhu, STEM Editor August 27, 2021

The US Food and Drug Association gave full approval to the Pfizer-BioNTech COVID-19 vaccine on Monday for individuals older than sixteen years. Previously, the treatment was only administered under an...

Senior Sachi Bajaj received her vaccine today. She and her family qualified to receive the vaccine as caregivers for her grandparents, who are at high risk of contracting the coronavirus.

Harker staff and students receive COVID-19 vaccinations, more scheduled this month

by Lucy Ge, Winged Post News Editor March 1, 2021

With upper school faculty and students beginning to receive their COVID-19 vaccines, more Harker staff are set to be vaccinated in Phase 1B of California’s vaccination plan.  All education workers,...

A nurse administers a dose of the Moderna vaccine to Cigeng Zhu, grandfather of Sabrina Zhu (10), at the Santa Clara Valley Medical Center. Those in high-risk groups, including healthcare workers, essential works, and the elderly, are given first priority.

Vaccine distributions advance in the U.S., California receives 5.7 million doses

by Sabrina Zhu, Assistant STEM Editor February 1, 2021

After the Pfizer and Moderna vaccines received emergency use authorization (EUA) by the Food and Drug Administration (FDA) in December, COVID-19 vaccinations have been initiated in all states in the U.S....

Countries across the world are currently rolling out three main versions of the COVID-19 vaccine from Pfizer, Moderna and AstraZeneca. The first vaccines were administered in December, with plans to complete a large portion of the rollout throughout 2021.

Comparing the COVID-19 vaccines: Pfizer, Moderna and AstraZeneca

by Sabrina Zhu, Assistant STEM Editor January 15, 2021

The first Pfizer-BioNTech COVID-19 vaccines were administered on Dec. 14 after being given emergency use authorization (EUA) by the Food and Drug Administration (FDA) on Dec. 11. Moderna also received...

The US Food and Drug Association gave full approval to the Pfizer-BioNTech COVID-19 vaccine on Monday for individuals older than sixteen years. Previously, the treatment was only administered under an emergency use authorization (EUA), which was granted in December 2020.

3 COVID-19 vaccines move forward after promising Phase 3 clinical trial data

by Mark Hu and Sabrina Zhu December 2, 2020

Biotechnology companies Pfizer, Moderna and AstraZeneca released first interim analysis reports from Phase 3 trials of their respective COVID-19 vaccines, all within the past month. The vaccines have efficacy...

In the United States, three companies — Moderna, Pfizer and AstraZeneca — have been conducting Phase 3 trials for a coronavirus vaccine. Phase 3 trials are the last step before a vaccine can be approved, with 30,000 volunteers participating in a study testing the efficacy of each vaccine.

SARS-CoV-2 vaccines continue Phase 3 trials, testing

by Aditya Singhvi, Aquila Co-Managing Editor September 28, 2020

As the coronavirus pandemic continues to expand, scientists around the globe are racing to develop and test an effective vaccine that can be approved for widespread use. In the United States, three...

Load More Stories